Katie Brouwer·Health journalist with a data-first approach. Compares vitamins, minerals, and supplements so you can make informed choices without the marketing noise.··9 min read
Which Iron Supplement Is Best for Absorption?
Not all iron supplements absorb the same way, and choosing the wrong form can mean weeks of side effects with little benefit. The research is clear that the form, dose, and timing of your iron supplement matter as much as the milligram count on the label.
What Is Iron and Why Does the Form Matter?
Iron is an essential mineral your body uses to make hemoglobin (the protein in red blood cells that carries oxygen) and myoglobin (the same protein in muscle tissue). When your iron stores run low, your cells get less oxygen, and fatigue, brain fog, and pale skin follow. But the form of iron in a supplement determines how efficiently your gut can pull it in.
Most iron supplements contain non-heme iron, which must be converted from the oxidized ferric state (Fe3+) to the reduced ferrous state (Fe2+) before your small intestine can absorb it. This conversion happens via an enzyme in your duodenum, and the iron then enters cells via divalent metal transporter 1 (DMT1). Once inside, iron is either stored or exported into your bloodstream through ferroportin, a channel regulated by the liver hormone hepcidin.
Ferrous forms, including ferrous sulfate, ferrous bisglycinate, ferrous fumarate, and ferrous gluconate, are already in the reduced, absorbable state. Chelated forms such as ferrous bisglycinate protect iron from binding to dietary inhibitors like phytates and polyphenols, which helps preserve bioavailability when you take iron with food[1][5]. In real-world conditions where most people do not fast before supplements, that chelation advantage matters.
Who Actually Needs an Iron Supplement?
Iron deficiency is one of the most common nutritional shortfalls worldwide, but it is not uniform across all groups. Knowing whether you are in a higher-risk population helps you decide whether to supplement and at what dose.
Pregnant women have substantially increased iron needs because they must supply iron to the developing fetus and expand blood volume by up to 50%. Clinical trials show that iron deficiency anemia (IDA) during pregnancy raises the risk of preterm birth and low birthweight. Menstruating women, children in rapid growth phases, people with inflammatory bowel disease (IBD), and those following a plant-based diet are also higher-risk groups.
A less obvious group deserves attention: people who are iron deficient but not yet anemic. According to a 2017 meta-analysis published in the , iron supplementation in non-anemic iron-deficient individuals significantly reduced fatigue, with a pooled effect size of 0.33 (95% CI 0.17 to 0.48; p<0.0001) across six RCTs. Long-term use of proton pump inhibitors (PPIs) is also a recognized risk factor: a meta-analysis of 14 studies found PPI users face a 2.56-fold higher risk of iron deficiency anemia (RR 2.56; 95% CI 1.43 to 4.61; p<0.00001).
Frequently Asked Questions
This content is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any supplement or making changes to your health regimen.
KB
Katie Brouwer
Health journalist with a data-first approach. Compares vitamins, minerals, and supplements so you can make informed choices without the marketing noise.
Health journalist with a data-first approach. Compares vitamins, minerals, and supplements so you can make informed choices without the marketing noise.
iron supplementiron absorptionferrous bisglycinateferrous sulfate
Related Articles
iron deficiency
Vitamins & Nutrients
Top 5 Nootropic Supplements Backed by Research
Lion's Mane, Bacopa Monnieri, phosphatidylserine, Rhodiola Rosea, and citicoline have the strongest clinical evidence among nootropics. Here's the data.
The clinical evidence paints a nuanced picture. Ferrous sulfate has been used for decades and remains the reference standard in most studies. A large systematic review and meta-analysis of 43 trials covering 6,831 adult participants confirmed its efficacy but also documented its GI cost: ferrous sulfate carries an odds ratio of 2.32 (95% CI 1.74 to 3.08) for gastrointestinal side effects compared to placebo, and 3.05 (95% CI 2.07 to 4.48) compared to intravenous iron[2].
Ferrous bisglycinate has attracted significant research attention as a gentler, potentially more bioavailable alternative. A 2023 systematic review and meta-analysis of 17 RCTs found that in pregnant women, ferrous bisglycinate raised hemoglobin by a standardized mean difference of 0.54 g/dL (95% CI 0.15 to 0.94; p<0.01) compared to other iron forms, while cutting gastrointestinal adverse events by 64% (incidence rate ratio 0.36; 95% CI 0.17 to 0.76; p<0.01)[1]. A double-blind RCT of 80 pregnant women also found that 25 mg of elemental iron as ferrous bisglycinate matched the IDA-prevention efficacy of 50 mg as ferrous sulfate, with significantly fewer GI complaints (p=0.001)[5]. That half-dose equivalence is clinically relevant for people who struggle with high-dose regimens.
Not every comparison has favored bisglycinate, however. A 2023 randomized noninferiority trial in 480 Cambodian women found that 18 mg of ferrous bisglycinate daily for 12 weeks failed to match 60 mg of ferrous sulfate for ferritin increase (84 µg/L vs. 99 µg/L; difference 14.6 µg/L)[6]. The takeaway: at very low doses in populations without severe deficiency, bisglycinate may not close the gap on its own. Dose still matters.
Prolonged-release ferrous sulfate offers a practical middle ground. A multicenter RCT of 399 women showed that an 80 mg prolonged-release formulation was non-inferior to a 105 mg standard-release formulation for hemoglobin recovery (difference 0.081 g/dL; NS), while producing significantly fewer moderate-to-severe GI adverse events (5.6% vs. 13.9%; p=0.007)[11]. If your main barrier to iron supplementation is tolerability, that formulation shift alone cuts the side-effect rate by more than half.
What to Watch Out For: Side Effects by Form
Side effects are the single biggest reason people stop taking iron supplements before their levels recover. Understanding the rates by formulation helps you set realistic expectations and choose the path most likely to lead to adherence.
A systematic review of 111 studies covering 10,695 patients found wide variation in adverse event rates across iron forms[7]. Plain ferrous sulfate had a 32.3% overall adverse event rate. Ferrous fumarate showed the highest rate at 47.0%. Ferrous gluconate came in at 30.9%. Extended-release ferrous sulfate combined with mucoproteose (a mucosal protective agent) had the lowest overall rate at just 4.1%, with a GI-specific rate of 3.7%. All differences versus the extended-release reference were statistically significant (p<0.001)[7].
The most common side effects across all ferrous forms are nausea, constipation, dark stools, and stomach cramping. These are dose-dependent to some degree and tend to be worst in the first one to two weeks of use. In pregnant women, ferrous sulfate raises the risk of GI side effects to an odds ratio of 3.33 versus placebo (95% CI 1.19 to 9.28)[2], making tolerability-guided form selection especially important in that population. The practical hierarchy: if plain ferrous sulfate causes intolerance, switching to a prolonged-release formulation, a bisglycinate chelate, or alternate-day dosing are all evidence-supported strategies before moving to intravenous iron[3][11].
How Timing and Interactions Shape Absorption
How and when you take iron can shift your absorption by more than 30%, independent of which form you choose. This is one of the most underappreciated aspects of iron supplementation.
The key regulator is hepcidin, a liver-produced hormone that blocks iron export from gut cells into circulation. After an oral iron dose of 60 mg or more, hepcidin rises within hours and stays elevated for roughly 24 hours. Consecutive daily dosing keeps hepcidin high, suppressing absorption on each subsequent day. Alternate-day dosing produced 34% higher cumulative fractional iron absorption (21.8% vs. 16.3%; p=0.0013) and 34% more total iron absorbed compared to consecutive daily dosing[4]. Split dosing twice daily actually elevated hepcidin without improving absorption[4].
PPIs are the most clinically significant drug interaction for iron. They raise gastric pH, which impairs the DcytB-mediated conversion of ferric to ferrous iron, and they also upregulate hepcidin expression, further suppressing absorption[9]. If you take a PPI, your oral iron response may be blunted regardless of form. Ferrous (pre-reduced) forms are preferable in that scenario since they bypass the pH-dependent conversion step.
Several dietary factors reduce absorption. Calcium above 300 mg competes with iron at the DMT1 transporter. Polyphenols in tea and coffee form poorly soluble complexes with ferrous iron. Phytates in whole grains reduce non-heme iron dose-dependently. Vitamin C is often added to iron supplements, but a 2023 meta-analysis of 905 participants found no significant improvement in hemoglobin (SMD 0.44; NS) or ferritin (SMD 0.03; NS) from co-supplementation[8]. Its benefit appears more pronounced in meal settings with high-inhibitor foods than at the supplement level.
How to Choose the Right Iron Supplement for Your Situation
Choosing an iron supplement is not a one-size-fits-all decision. The right answer depends on your deficiency severity, your history of GI side effects, your life stage, and any medications you take.
For confirmed iron deficiency anemia, 60 to 100 mg of elemental ferrous iron daily is a well-supported starting point, with alternate-day dosing to improve fractional absorption by approximately one-third[4]. For pregnancy, 25 mg of ferrous bisglycinate or 30 to 60 mg of ferrous sulfate daily is adequate for IDA prevention, with bisglycinate preferred for GI tolerability[1][5]. For iron deficiency without anemia, lower doses of 18 to 40 mg per day of bisglycinate or prolonged-release sulfate are appropriate[10].
If you have a history of oral iron intolerance, try a prolonged-release formulation or bisglycinate chelate first, then trial alternate-day dosing, before escalating to intravenous iron[3][7][11]. Intermittent supplementation (one to three times per week) produces comparable anemia outcomes to daily dosing in menstruating women, with 59% fewer adverse effects (RR 0.41; 95% CI 0.21 to 0.82) per a Cochrane review of 25 RCTs and nearly 11,000 women[3]. Take iron on an empty stomach when possible, keep it away from calcium and high-polyphenol beverages, and space it from any PPI dose by several hours.
Frequently Asked Questions
Q. What is the difference between ferrous and ferric iron supplements?
Ferrous iron (Fe2+) is already in the reduced, absorbable form your small intestine uses directly. Ferric iron (Fe3+) must first be converted to ferrous iron by an enzyme in your gut before it can be absorbed, and that conversion is impaired by low stomach acid — for example, in people taking PPIs[9]. Ferrous forms such as ferrous sulfate, ferrous bisglycinate, and ferrous fumarate tend to have higher and more consistent absorption than ferric forms, though ferric maltol is a newer option with improved GI tolerability that has shown comparable efficacy in some populations.
Q. Is ferrous bisglycinate better than ferrous sulfate?
Ferrous bisglycinate is better tolerated and absorbs comparably or better at lower doses in many populations, particularly pregnant women[1][5]. However, at very low doses (18 mg) in populations without severe deficiency, it may not match 60 mg of ferrous sulfate for raising ferritin levels[6]. If GI side effects have led you to stop taking ferrous sulfate in the past, bisglycinate or a prolonged-release ferrous sulfate formulation are clinically reasonable alternatives with strong tolerability data[7][11].
Q. Does taking iron every other day really improve absorption?
Yes, and the data is specific. An RCT found that alternate-day dosing improved cumulative fractional iron absorption by 34% compared to consecutive daily dosing, because spacing doses allows hepcidin levels to fall back to baseline before the next dose[4]. Taking iron twice daily actually worsens the situation by keeping hepcidin elevated throughout the day. If you are on a daily iron regimen and not seeing the response you expect, asking your provider about alternate-day dosing is worth considering.
Q. Can I take iron supplements with my morning coffee or tea?
Coffee and tea contain polyphenols that bind ferrous iron in your gut and reduce absorption — potentially by up to 45% depending on the polyphenol load. If you take iron in the morning, separating it from your coffee or tea by at least one to two hours helps preserve absorption. If that is difficult, choosing a chelated form like ferrous bisglycinate may partially offset the inhibition because the chelate structure protects iron from binding to dietary compounds[1].
Q. I take a proton pump inhibitor. Will iron supplements still work?
PPI use raises your risk of iron deficiency anemia 2.56-fold[9], and it can also blunt your response to oral iron supplementation by impairing the conversion of ferric iron to ferrous iron and by upregulating hepcidin. Ferrous (pre-reduced) iron forms are preferable if you are on a PPI because they bypass the pH-dependent conversion step. In some cases, oral iron may be insufficiently effective in PPI users, and a healthcare provider may consider IV iron instead. This is a decision best made with your prescribing clinician.
References
[1] Fischer JAJ et al., "The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials," Nutrition Reviews, 2023. DOI: 10.1093/nutrit/nuac106
[2] Tolkien Z et al., "Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis," PLoS ONE, 2015. DOI: 10.1371/journal.pone.0117383
[3] Fernandez-Gaxiola AC & De-Regil LM, "Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women," Cochrane Database of Systematic Reviews, 2019. DOI: 10.1002/14651858.CD009218.pub3
[4] Stoffel NU et al., "Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials," Lancet Haematology, 2017. DOI: 10.1016/S2352-3026(17)30182-5
[5] Milman N et al., "Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial," Journal of Perinatal Medicine, 2014. DOI: 10.1515/jpm-2013-0153
[6] Fischer JAJ et al., "Is a Lower Dose of More Bioavailable Iron (18-mg Ferrous Bisglycinate) Noninferior to 60-mg Ferrous Sulfate in Increasing Ferritin Concentrations While Reducing Gut Inflammation and Enteropathogen Detection in Cambodian Women? A Randomized Controlled Noninferiority Trial," The Journal of Nutrition, 2023. DOI: 10.1016/j.tjnut.2023.05.029
[7] Cancelo-Hidalgo MJ et al., "Tolerability of different oral iron supplements: a systematic review," Current Medical Research and Opinion, 2013. DOI: 10.1185/03007995.2012.761599
[8] Loganathan V et al., "Treatment efficacy of vitamin C or ascorbate given as co-intervention with iron for anemia: A systematic review and meta-analysis of experimental studies," Clinical Nutrition ESPEN, 2023. DOI: 10.1016/j.clnesp.2023.07.081
[9] Ali MD, "Proton Pump Inhibitors' Use and Risk of Iron Deficiency Anaemia: A Systematic Review and Meta-analysis," Current Reviews in Clinical and Experimental Pharmacology, 2023. DOI: 10.2174/2772432817666220307121220
[10] Yokoi K & Konomi A, "Iron deficiency without anaemia is a potential cause of fatigue: meta-analyses of randomised controlled trials and cross-sectional studies," British Journal of Nutrition, 2017. DOI: 10.1017/S0007114517001349
[11] Zaim M et al., "Efficacy and tolerability of a prolonged release ferrous sulphate formulation in iron deficiency anaemia: a non-inferiority controlled trial," European Journal of Nutrition, 2012. DOI: 10.1007/s00394-011-0210-7
This content is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any supplement or making changes to your health regimen.